4,6-dimethoxy-2-methylpyrimidin-5-amine

4,6-dimethoxy-2-methylpyrimidin-5-amine is a key intermediate in the preparation of high-value pharmaceutical scaffolds and exhibits structural relevance to precursors used in the synthesis of the antihypertensive drug Moxonidine; this compound participates in patented routes involving imidazoline group introduction and selective methoxylation, highlighting its importance for pyrimidine-based drug development.